메뉴 건너뛰기




Volumn 542, Issue , 2009, Pages 285-300

Using in vivo biopanning for the development of radiation-guided drug delivery systems

Author keywords

Biopanning; drug delivery system; mice; phage display; radiosensitization; radiotherapy; T7 bacteriophage; treatment induced biomarker; tumor cells

Indexed keywords

BACTERIA (MICROORGANISMS); MUS;

EID: 67650284487     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-561-9_15     Document Type: Article
Times cited : (4)

References (49)
  • 1
    • 4344670729 scopus 로고    scopus 로고
    • A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction
    • Geng , L. , J. Tan , et al.2004) "A specific antagonist of the p110delta catalytic component of phosphatidylinositol 3'-kinase, IC486068, enhances radiation-induced tumor vascular destruction. Cancer Res 64 (14) : 4893-9
    • (2004) Cancer Res. , vol.64 , Issue.14 , pp. 4893-4899
    • Geng, L.1    Tan, J.2
  • 2
    • 0041672482 scopus 로고    scopus 로고
    • SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models
    • Schueneman , A. J. , E. Himmelfarb , et al.2003) "SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models. Cancer Res 63 (14) : 4009-16
    • (2003) Cancer Res. , vol.63 , Issue.14 , pp. 4009-4016
    • Schueneman, A.J.1    Himmelfarb, E.2
  • 3
    • 40449108294 scopus 로고    scopus 로고
    • Noninvasive assessment of cancer response to therapy
    • Han , Z. , A. Fu , et al.2008) "Noninvasive assessment of cancer response to therapy. Nat Med 14 (3) : 343-9
    • (2008) Nat. Med. , vol.14 , Issue.3 , pp. 343-389
    • Han, Z.1    Fu., A.2
  • 4
    • 37849044904 scopus 로고    scopus 로고
    • A phase i study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma
    • Duffy , A. , J. Kortmansky , et al.2008) "A phase I study of erlotinib in combination with gemcitabine and radiation in locally adVanced, non-operable pancreatic adenocarcinoma. Ann Oncol 19 (1) : 86-91
    • (2008) Ann. Oncol. , vol.19 , Issue.1 , pp. 86-91
    • Duffy, A.1    Kortmansky, J.2
  • 5
    • 29044433659 scopus 로고    scopus 로고
    • Erlotinib and chemoradiation followed by maintenance erlotinib for locally and vanced pancreatic cancer: A phase i study
    • Iannitti , D. , T. Dipetrillo , et al.2005) "Erlotinib and chemoradiation followed by maintenance erlotinib for locally adVanced pancreatic cancer: a phase I study. Am J Clin Oncol 28 (6) : 570-5
    • (2005) Am. J. Clin. Oncol. , vol.28 , Issue.6 , pp. 570-385
    • Iannitti, D.1    Dipetrillo, T.2
  • 6
    • 33745183568 scopus 로고    scopus 로고
    • Phase i trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of north central cancer treatment group protocol n0177
    • Krishnan , S. , P. D. Brown , et al.2006) "Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. Int J Radiat Oncol Biol Phys 65 (4) : 1192-9
    • (2006) Int. J. Radiat. Oncol. Biol. Phys. , vol.65 , Issue.4 , pp. 1192-1199
    • Krishnan, S.1    Brown, P.D.2
  • 7
    • 1642576220 scopus 로고    scopus 로고
    • Enhanced radiation-induced cell killing andprolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275
    • Camphausen , K. , W. Burgan , et al.2004) "Enhanced radiation-induced cell killing andprolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275. Cancer Res 64 (1) : 316-21
    • (2004) Cancer Res. , vol.64 , Issue.1 , pp. 316-321
    • Camphausen, K.1    Burgan, W.2
  • 8
    • 34748877735 scopus 로고    scopus 로고
    • Inhibition of histone deacetylation: A strategy for tumor radiosensitization
    • Camphausen , K. and P. J. Tofilon (2007) "Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 25 (26) : 4051-6
    • (2007) J. Clin. Oncol. , vol.25 , Issue.26 , pp. 4051-4056
    • Camphausen, K.1    Tofilon, P.J.2
  • 9
    • 34250805910 scopus 로고    scopus 로고
    • Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation
    • Cuneo , K. C. , A. Fu , et al.2007) "Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Anticancer Drugs 18 (7) : 793-800
    • (2007) Anticancer Drugs , vol.18 , Issue.7 , pp. 793-800
    • Cuneo, K.C.1    Fu., A.2
  • 10
    • 33845741562 scopus 로고    scopus 로고
    • Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer
    • Geng , L. , K. C. Cuneo , et al.2006) "Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer. Cancer Res 66 (23) : 11298-304
    • (2006) Cancer Res. , vol.66 , Issue.23 , pp. 11298-304
    • Geng, L.1    Cuneo, K.C.2
  • 11
    • 0036828101 scopus 로고    scopus 로고
    • MS-27- 275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors
    • Jaboin , J. , J. Wild , et al.2002) "MS-27- 275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res 62 (21) : 6108-15
    • (2002) Cancer Res. , vol.62 , Issue.21 , pp. 6108-6115
    • Jaboin, J.1    Wild, J.2
  • 12
    • 34547662889 scopus 로고    scopus 로고
    • Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models
    • Qian , D. Z. , Y. F. Wei , et al.2007) "Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models. Prostate 67 (11) : 1182-93
    • (2007) Prostate , vol.67 , Issue.11 , pp. 1182-1193
    • Qian, D.Z.1    Wei, Y.F.2
  • 13
    • 0034566035 scopus 로고    scopus 로고
    • Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation
    • Colletier , P. J. , F. Ashoori , et al.2000) "Adenoviral-mediated p53 transgene expression sensitizes both wild-type and null p53 prostate cancer cells in vitro to radiation. Int J Radiat Oncol Biol Phys 48 (5) : 1507-12
    • (2000) Int. J. Radiat. Oncol. Biol. Phys. , vol.48 , Issue.5 , pp. 1507-1512
    • Colletier, P.J.1    Ashoori, F.2
  • 14
    • 28844461720 scopus 로고    scopus 로고
    • Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: A strategy to convert a radio-resistant phenotype into a radiosensitive one
    • D'Avenia , P. , A. Porrello , et al.2006) "Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one. Cancer Lett 231 (1) : 102-12
    • (2006) Cancer Lett. , vol.231 , Issue.1 , pp. 102-112
    • D'Avenia, P.1    Porrello, A.2
  • 15
    • 0030969022 scopus 로고    scopus 로고
    • P53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy
    • Pirollo , K. F. , Z. Hao , et al.1997) "p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Oncogene 14 (14) : 1735-46
    • (1997) Oncogene , vol.14 , Issue.14 , pp. 1735-1746
    • Pirollo, K.F.1    Hao, Z.2
  • 16
    • 30944466631 scopus 로고    scopus 로고
    • Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial
    • Atencio , I. A. , M. Grace , et al.2006) "Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial. Cancer Gene Ther 13 (2) : 169-81
    • (2006) Cancer Gene. Ther. , vol.13 , Issue.2 , pp. 169-181
    • Atencio, I.A.1    Grace, M.2
  • 17
    • 33645829571 scopus 로고    scopus 로고
    • Multicenter phase i study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer
    • Fujiwara , T. , N. Tanaka , et al.2006) "Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with adVanced non-small-cell lung cancer. J Clin Oncol 24 (11) : 1689-99
    • (2006) J. Clin. Oncol. , vol.24 , Issue.11 , pp. 1689-1699
    • Fujiwara, T.1    Tanaka, N.2
  • 18
    • 33744529601 scopus 로고    scopus 로고
    • Phase I/II adenoviral p53 gene therapy for chemoradiation resistant adVanced esophageal squamous cell carcinoma
    • Shimada , H. , H. Matsubara , et al.2006) "Phase I/II adenoviral p53 gene therapy for chemoradiation resistant adVanced esophageal squamous cell carcinoma. Cancer Sci 97 (6) : 554-61
    • (2006) Cancer Sci. , vol.97 , Issue.6 , pp. 554-561
    • Shimada, H.1    Matsubara, H.2
  • 19
    • 33646457691 scopus 로고    scopus 로고
    • Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with adVanced cancer
    • Tolcher , A. W. , D. Hao , et al.2006) "Phase I, pharmacokinetic, and pharmacodynamic study of intravenously administered Ad5CMV-p53, an adenoviral vector containing the wild-type p53 gene, in patients with adVanced cancer. J Clin Oncol 24 (13) : 2052-8
    • (2006) J. Clin. Oncol. , vol.24 , Issue.13 , pp. 2052-2058
    • Tolcher, A.W.1    Hao, D.2
  • 20
    • 0042566165 scopus 로고    scopus 로고
    • Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer
    • Swisher , S. G. , J. A. Ajani , et al.2003) "Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally adVanced esophageal cancer. Int J Radiat Oncol Biol Phys 57 (1) : 120-7
    • (2003) Int. J. Radiat. Oncol. Biol. Phys. , vol.57 , Issue.1 , pp. 120-387
    • Swisher, S.G.1    Ajani, J.A.2
  • 21
    • 7444243914 scopus 로고    scopus 로고
    • Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53
    • Cook , T. , Z. Wang , et al.2004) "Nitric oxide and ionizing radiation synergistically promote apoptosis and growth inhibition of cancer by activating p53. Cancer Res 64 (21) : 8015-21
    • (2004) Cancer Res. , vol.64 , Issue.21 , pp. 8015-8021
    • Cook, T.1    Wang, Z.2
  • 22
    • 0742304419 scopus 로고    scopus 로고
    • Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuVant-induced arthritis in rats
    • Hildebrandt , G. , A. Radlingmayr , et al.2003) "Low-dose radiotherapy (LD-RT) and the modulation of iNOS expression in adjuVant-induced arthritis in rats. Int J Radiat Biol 79 (12) : 993-1001
    • (2003) Int. J. Radiat. Biol. , vol.79 , Issue.12 , pp. 993-91001
    • Hildebrandt, G.1    Radlingmayr, A.2
  • 23
    • 1242338769 scopus 로고    scopus 로고
    • Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity
    • Wang , Z. , T. Cook , et al.2004) "Adenoviral gene transfer of the human inducible nitric oxide synthase gene enhances the radiation response of human colorectal cancer associated with alterations in tumor vascularity. Cancer Res 64 (4) : 1386-95
    • (2004) Cancer Res. , vol.64 , Issue.4 , pp. 1386-1395
    • Wang, Z.1    Cook, T.2
  • 24
    • 0030124517 scopus 로고    scopus 로고
    • Acyclic nucleosides as antiviral compounds
    • Freeman , S. and J. M. Gardiner (1996) "Acyclic nucleosides as antiviral compounds. Mol Biotechnol 5 (2) : 125-37
    • (1996) Mol. Biotechnol. , vol.5 , Issue.2 , pp. 125-137
    • Freeman, S.1    Gardiner, J.M.2
  • 25
    • 0346243603 scopus 로고    scopus 로고
    • Adenovirus/ herpes simplex-thymidine kinase/ ganciclovir complex: Preliminary results of phase i trial in patients with recurrent malignant gliomas
    • Germano , I. M. , J. Fable , et al.2003) "Adenovirus/ herpes simplex-thymidine kinase/ ganciclovir complex: preliminary results of phase I trial in patients with recurrent malignant gliomas. J Neurooncol 65 (3) : 279-89
    • (2003) J. Neurooncol. , vol.65 , Issue.3 , pp. 279-289
    • Germano, I.M.1    Fable, J.2
  • 26
    • 2442767029 scopus 로고    scopus 로고
    • Phase I/II study of herpes simplex virus type 1 thymidine kinase suicide
    • Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther
    • Klatzmann , D. , C. A. Valery , et al.1998) "phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther 9 (17) : 2595-604
    • (1998) Gene. Therapy for Recurrent Glioblastoma , vol.9 , Issue.17 , pp. 2595-604
    • Klatzmann, D.1    Valery., C.A.2
  • 27
    • 0034694011 scopus 로고    scopus 로고
    • A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuVant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme
    • Rainov , N. G.2000) "A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuVant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther 11 (17) : 2389-401
    • (2000) Hum. Gene. Ther. , vol.11 , Issue.17 , pp. 2389-401
    • Rainov, N.G.1
  • 28
    • 10744227813 scopus 로고    scopus 로고
    • Phase i study of replication-competent adenovirus- mediated double-suicide gene therapy in combination with conventional-dose threedimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer
    • Freytag , S. O. , H. Stricker , et al.2003) "Phase I study of replication-competent adenovirus- mediated double-suicide gene therapy in combination with conventional-dose threedimensional conformal radiation therapy for the treatment of newly diagnosed, intermediate- to high-risk prostate cancer. Cancer Res 63 (21) : 7497-506
    • (2003) Cancer Res. , vol.63 , Issue.21 , pp. 7497-506
    • Freytag, S.O.1    Stricker, H.2
  • 29
    • 0035879042 scopus 로고    scopus 로고
    • CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity
    • Chen , Y. , T. DeWeese , et al.2001) "CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity. Cancer Res 61 (14) : 5453-60
    • (2001) Cancer Res. , vol.61 , Issue.14 , pp. 5453-5460
    • Chen, Y.1    Deweese, T.2
  • 30
    • 22944434253 scopus 로고    scopus 로고
    • Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity
    • Dilley , J. , S. Reddy , et al.2005) "Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity. Cancer Gene Ther 12 (8) : 715-22
    • (2005) Cancer Gene. Ther. , vol.12 , Issue.8 , pp. 715-722
    • Dilley, J.1    Reddy, S.2
  • 31
    • 0035887153 scopus 로고    scopus 로고
    • A phase i trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy
    • DeWeese , T. L. , H. Van der Poel , et al.2001) "A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy. Cancer Res 61 (20) : 7464-72
    • (2001) Cancer Res. , vol.61 , Issue.20 , pp. 7464-7472
    • Deweese, T.L.1    Der H.Van2
  • 32
    • 33745161873 scopus 로고    scopus 로고
    • A phase i trial of intravenous CG7870, a replication- selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer
    • Small , E. J. , M. A. Carducci , et al.2006) " phase I trial of intravenous CG7870, a replication- selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer. Mol Ther 14 (1) : 107-17
    • (2006) Mol. Ther. , vol.14 , Issue.1 , pp. 107-117
    • Small, E.J.1    Carducci, M.A.2
  • 34
    • 0032534024 scopus 로고    scopus 로고
    • X-ray-induced P-selectin localization to the lumen of tumor blood vessels
    • Hallahan , D. E. , M. J. Staba-Hogan , et al.1998) "X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res 58 (22) : 5216-20
    • (1998) Cancer Res. , vol.58 , Issue.22 , pp. 5216-5220
    • Hallahan, D.E.1    Staba-Hogan, M.J.2
  • 35
    • 0029561153 scopus 로고
    • E-selectin gene induction by ionizing radiation is independent of cytokine induction
    • Hallahan , D. , E. T. Clark , et al.1995) "E-selectin gene induction by ionizing radiation is independent of cytokine induction. Biochem Biophys Res Commun 217 (3) : 784-95
    • (1995) Biochem. Biophys. Res. Commun. , vol.217 , Issue.3 , pp. 784-795
    • Hallahan, D.1    Clark, E.T.2
  • 36
    • 0029861338 scopus 로고    scopus 로고
    • Radiation-mediated gene expression in the pathogenesis of the clinical radiation response
    • Hallahan , D. E.1996) "Radiation-mediated gene expression in the pathogenesis of the clinical radiation response. Semin Radiat Oncol 6 (4) : 250-67
    • (1996) Semin. Radiat. Oncol. , vol.6 , Issue.4 , pp. 250-267
    • Hallahan, D.E.1
  • 37
    • 0033212094 scopus 로고    scopus 로고
    • Drug-radiation interactions in tumor blood vessels
    • Hallahan , D. E. , A. Y. Chen , et al.1999) "Drug-radiation interactions in tumor blood vessels. Oncology (Williston Park) 13 (10 Suppl 5) : 71-7
    • (1999) Oncology (Williston Park) , vol.13 , Issue.10 SUPPL. 5 , pp. 71-7
    • Hallahan, D.E.1    Chen, A.Y.2
  • 38
    • 0032535999 scopus 로고    scopus 로고
    • Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
    • Arap , W. , R. Pasqualini , et al.1998) "Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 (5349) : 377-80
    • (1998) Science , vol.279 , Issue.5349 , pp. 377-380
    • Arap, W.1    Pasqualini, R.2
  • 39
    • 0033597209 scopus 로고    scopus 로고
    • Membrane dipeptidase is the receptor for a lungtargeting peptide identified by in vivo phage display
    • Rajotte , D. and E. Ruoslahti (1999) "Membrane dipeptidase is the receptor for a lungtargeting peptide identified by in vivo phage display. J Biol Chem 274 (17) : 11593-8
    • (1999) J. Biol. Chem. , vol.274 , Issue.17 , pp. 11593-11598
    • Rajotte, D.1    Ruoslahti, E.2
  • 40
    • 0038162536 scopus 로고    scopus 로고
    • Integrinmediated targeting of drug delivery to irradiated tumor blood vessels
    • Hallahan , D. , L. Geng , et al.2003) "Integrinmediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell 3 : 63-74
    • (2003) Cancer Cell , vol.3 , pp. 63-74
    • Hallahan, D.1    Geng, L.2
  • 41
    • 0029932458 scopus 로고    scopus 로고
    • Organ targeting in vivo using phage display peptide libraries. "
    • Pasqualini , R. and E. Ruoslahti (1996) "Organ targeting in vivo using phage display peptide libraries. " Nature 380 (6572) : 364-6
    • (1996) Nature , vol.380 , Issue.6572 , pp. 364-386
    • Pasqualini, R.1    Ruoslahti, E.2
  • 42
    • 0346982051 scopus 로고    scopus 로고
    • Phage display
    • Smith , G. P. and V. A. Petrenko (1997) "Phage Display. Chem Rev 97 (2) : 391-410
    • (1997) Chem. Rev. , vol.97 , Issue.2 , pp. 391-410
    • Smith, G.P.1    Petrenko, V.A.2
  • 43
    • 0033961964 scopus 로고    scopus 로고
    • Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models
    • Staba , M. J. , T. J. Wickham , et al.2000) "Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Ther 7 (1) : 13-9
    • (2000) Cancer Gene. Ther. , vol.7 , Issue.1 , pp. 13-19
    • Staba, M.J.1    Wickham, T.J.2
  • 44
    • 84858378956 scopus 로고    scopus 로고
    • Radiation- guided P-selectin targeted antibody to lung cancer
    • in press ).
    • Hariri, G., Y. Zhang, et al.2008). "Radiation- guided P-selectin targeted antibody to lung cancer. Ann Biomed Eng (in press ).
    • (2008) Ann. Biomed. Eng.
    • Hariri, G.1    Zhang, Y.2
  • 45
    • 0035866771 scopus 로고    scopus 로고
    • Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy
    • Geng , L. , E. Donnelly , et al.2001) "Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy. Cancer Res 61 (6) : 2413-9
    • (2001) Cancer Res. , vol.61 , Issue.6 , pp. 2413-2419
    • Geng, L.1    Donnelly, E.2
  • 46
    • 1242293097 scopus 로고    scopus 로고
    • Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium
    • Lu , B. , L. Geng , et al.2004) "Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium. Int J Radiat Oncol Biol Phys 58 (3) : 844-50
    • (2004) Int. J. Radiat. Oncol. Biol. Phys. , vol.58 , Issue.3 , pp. 844-850
    • Lu, B.1    Geng, L.2
  • 47
    • 0029803150 scopus 로고    scopus 로고
    • Cell adhesion molecules mediate radiationinduced leukocyte adhesion to the vascular endothelium
    • Hallahan , D. , J. Kuchibhotla , et al.1996) "Cell adhesion molecules mediate radiationinduced leukocyte adhesion to the vascular endothelium. Cancer Res 56 (22) : 5150-5
    • (1996) Cancer Res. , vol.56 , Issue.22 , pp. 5150-5155
    • Hallahan, D.1    Kuchibhotla, J.2
  • 48
    • 0035816144 scopus 로고    scopus 로고
    • Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature
    • Hallahan , D. E. , L. Geng , et al.2001) "Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature. J Control Rel 74 (1-3) : 183-91
    • (2001) J. Control. Rel. , vol.74 , Issue.1-3 , pp. 183-191
    • Hallahan, D.E.1    Geng, L.2
  • 49
    • 33644839612 scopus 로고    scopus 로고
    • Signaling mechanisms regulating endothelial permeability
    • Mehta , D. and A. B. Malik (2006) "Signaling mechanisms regulating endothelial permeability. Physiol Rev 86 (1) : 279-367
    • (2006) Physiol. Rev. , vol.86 , Issue.1 , pp. 279-367
    • Mehta, D.1    Malik, A.B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.